CLPS and tuberculosis: This observation is of potential clinical significance since anti-tuberculosis drugs such as cyclomarin A [30,37] and lassomycin [38,39] are expected to bind to the ClpC1-NTD, thereby leading to competition for binding between ClpS and anti-tuberculosis drug.